Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Infect Dis ; 38(4): e36-7, 2004 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-14765362

RESUMO

Medicinal leeches have an important and expanding role in medicine, but infection can complicate their use. We describe a unique case of Aeromonas meningitis associated with the use of leech therapy to salvage a skin flap after central nervous system surgery.


Assuntos
Aeromonas/isolamento & purificação , Infecções por Bactérias Gram-Negativas/etiologia , Sanguessugas/microbiologia , Aplicação de Sanguessugas/efeitos adversos , Meningite/etiologia , Adulto , Animais , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Humanos , Masculino , Meningite/tratamento farmacológico
2.
Antimicrob Agents Chemother ; 47(8): 2659-62, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12878536

RESUMO

Reported rates of nephrotoxicity associated with the systemic use of polymyxins have varied widely. The emergence of infections due to multiresistant gram-negative bacteria has necessitated the use of systemic polymyxin B once again for the treatment of such infections. We retrospectively investigated the rate of nephrotoxicity in patients receiving polymyxin B parenterally for the treatment of infections caused by multiresistant gram-negative bacteria from October 1999 to September 2000. Demographic and clinical information was obtained for 60 patients. Outcome measures of interest were renal toxicity and clinical and microbiologic efficacy. Renal failure developed in 14% of the patients, all of whom had normal baseline renal function. Development of renal failure was independent of the daily and cumulative doses of polymyxin B and the length of treatment but was significantly associated with older age (76 versus 59 years, P = 0.02). The overall mortality was 20%, but it increased to 57% in those who developed renal failure. The organism was cleared in 88% of the patients from whom repeat specimens were obtained. The use of polymyxin B to treat multiresistant gram-negative infections was highly effective and associated with a lower rate of nephrotoxicity than previously described.


Assuntos
Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Nefropatias/induzido quimicamente , Polimixina B/efeitos adversos , Polimixina B/uso terapêutico , Acinetobacter baumannii/efeitos dos fármacos , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Creatinina/sangue , Infecção Hospitalar/microbiologia , Farmacorresistência Bacteriana Múltipla , Feminino , Seguimentos , Infecções por Bactérias Gram-Negativas/microbiologia , Infecções por Bactérias Gram-Negativas/mortalidade , Humanos , Masculino , Pessoa de Meia-Idade , Pseudomonas aeruginosa/efeitos dos fármacos , Respiração Artificial , Estudos Retrospectivos , Análise de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA